Clinical trial · Observational
Evaluation of the Impact of Chemotherapy on Body Odor in Adolescents and Young Adults in Oncology
ODORAJA:Evaluation of the Impact of Chemotherapy on Body Odor in Adolescents and Young Adults in Oncology
NCT04899505CI-TRIAL-00089776ODORAJAcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The appearance of unpleasant body odors in adolescent Young adult (aya) wille be evaluated undergoing chemotherapy
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Chemotherapy Effect | — | UNRESOLVED | — |
| Solid Tumor, Adult | Adult Solid Neoplasm | ALIAS | 0.90 |
| Solid Tumor, Childhood | Childhood Solid Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Evaluation on appearance of unpleasant body odors | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Evaluation on appearance of unpleasant body odors
- description
- Incidence of the development of unpleasant body odors in AYA oncology patients
- interventionNames
- Other: Evaluation on appearance of unpleasant body odors
Primary outcomes (1)
- measure
- Incidence of the development of unpleasant body odors in AYA oncology patients
- timeFrame
- 8 months
- description
- Percentage of patients reporting discomfort with unpleasant body odor that occurred during their treatment. This percentage will be calculated from the response to item Q1 of the patient questionnaire during the fourth course of chemotherapy in the AJA oncology department
Secondary outcomes (3)
- measure
- Qualification of the smell and the discomfort felt
- timeFrame
- 8 months
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 15 Years
- Maximum age
- 25 Years
Show eligibility criteria text
Inclusion Criteria: * Patients aged between 15 and 25 years; * New patients treated at the Curie Institute and hospitalized in the AJA oncology department; * Patient undergoing chemotherapy administered intravenously; * Solid tumors. Exclusion Criteria: * Patient undergoing oral chemotherapy; * Persons deprived of their liberty or under guardianship (including guardianship); * Inability to undergo medical monitoring of the trial for geographical, social or psychological reasons.
References
Publications (0)
Data not yet available
No reference posted for this study.